| 1 |
Guy Bemis |
Vertex Pharmaceuticals Incorporated |
9 |
| 2 |
Patrizio Vinciarelli |
Vlt |
8 |
| 2 |
Seok-Hyun Yun |
The General Hospital |
8 |
| #4 |
William Plumb |
Mediatek |
6 |
| #4 |
Tao Kai Lam |
Emc |
6 |
| #4 |
Jun Yuan |
Neurogen |
6 |
| #7 |
Philip Youngman |
Millennium Pharmaceuticals |
5 |
| #8 |
Kevin J. McCallion |
Finisar |
4 |
| #8 |
Luz-Maria Guzman |
Millennium Pharmaceuticals |
4 |
| #8 |
Jen Sheen |
The General Hospital |
4 |
| #8 |
Julian Adams |
Infinity Pharmaceuticals |
4 |
| #8 |
Randall B. Lauffer |
The General Hospital |
4 |
| #8 |
E. Antonio Chiocca |
The General Hospital |
4 |
| #8 |
David A. Bulpett |
Acushnet |
4 |
| #8 |
Craig M. Carpenter |
Micron |
4 |
| #8 |
Francois Maltais |
Vertex Pharmaceuticals Incorporated |
4 |
| #8 |
Ralph de la Torre |
Medcanica |
4 |
| #8 |
Scott R. Adler |
— |
4 |
| #8 |
Laurie H. Glimcher |
Harvard University |
4 |
| #8 |
Juha-Pekka J. Laine |
Draper Laboratory |
4 |
| #21 |
Denise L. Faustman |
The General Hospital |
3 |
| #21 |
Carl J. Kraenzel |
IBM |
3 |
| #21 |
David Boas |
The General Hospital |
3 |
| #21 |
Ngwe Cheong |
Kopin |
3 |
| #21 |
Brendan Welch |
The Ensign-Bickford |
3 |
| #21 |
Albert Jean Robichaud |
Sage Therapeutics |
3 |
| #21 |
Jakob Maya |
Panasonic |
3 |
| #21 |
Jean L. Spencer |
Gillett Canada |
3 |
| #21 |
Jon P. Wade |
Thinking Machines |
3 |
| #21 |
Michael S. Malamas |
Amerimas Home Products |
3 |
| #21 |
Farhad Hakimi |
MIT |
3 |
| #21 |
George G. Mueller |
Color Kinetics Incorporated |
3 |
| #21 |
Clive Tucker |
Clearmotion |
3 |
| #21 |
Jean-Pierre Sommadossi |
Idenix Pharmaceuticals |
3 |
| #21 |
Dan Arnon |
Emc |
3 |
| #21 |
Gregory L. Verdine |
Harvard University |
3 |
| #21 |
Leszek Hozer |
Sarnoff |
3 |
| #38 |
Richard Crump |
Nortel Networks Limited |
2 |
| #38 |
Yves Schabes |
Global Information Research And Technologies |
2 |
| #38 |
Anthony J. Sinskey |
MIT |
2 |
| #38 |
Edward C. Carman, Jr. |
— |
2 |
| #38 |
Benjamin Janes Beck |
The Procter & Gamble |
2 |
| #38 |
Anibal A. Arjona |
Boston Heart Foundation |
2 |
| #38 |
Nathanael S. Gray |
Dana-Farber Cancer Institute |
2 |
| #38 |
David C. Rogers |
Artisent |
2 |
| #38 |
Sylvain Vauthey |
MIT |
2 |
| #38 |
Harry L. Ceccon |
Cynosure |
2 |
| #38 |
Brian Seed |
The General Hospital |
2 |
| #38 |
Donald E. Ingber |
Harvard University |
2 |
| #38 |
Vincent A. O'Byrne |
Verizon |
2 |